132 related articles for article (PubMed ID: 27884394)
1. [Mitomycin-induced pulmonary veno-occlusive disease: A rare but severe complication].
Montani D; Chaumais MC; Seferian A; Humbert M
Bull Cancer; 2017 Feb; 104(2):202-204. PubMed ID: 27884394
[No Abstract] [Full Text] [Related]
2. Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models.
Perros F; Günther S; Ranchoux B; Godinas L; Antigny F; Chaumais MC; Dorfmüller P; Hautefort A; Raymond N; Savale L; Jaïs X; Girerd B; Cottin V; Sitbon O; Simonneau G; Humbert M; Montani D
Circulation; 2015 Sep; 132(9):834-47. PubMed ID: 26130118
[TBL] [Abstract][Full Text] [Related]
3. Lung transplantation for mitomycin-induced pulmonary veno-occlusive disease.
Savale L; Chaumais MC; Dorfmuller P; Humbert M; Montani D
Presse Med; 2017 Dec; 46(12 Pt 1):1223-1225. PubMed ID: 29129416
[No Abstract] [Full Text] [Related]
4. Response to Letter Regarding Article, "Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Model".
Perros F; Günther S; Ranchoux B; Godinas L; Antigny F; Chaumais MC; Dorfmüller P; Hautefort A; Raymond N; Savale L; Jaïs X; Girerd B; Cottin V; Sitbon O; Simonneau G; Humbert M; Montani D
Circulation; 2016 Apr; 133(14):e592-3. PubMed ID: 27045136
[No Abstract] [Full Text] [Related]
5. Letter by Belge et al Regarding Article, "Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models".
Belge C; Quarck R; Delcroix M
Circulation; 2016 Apr; 133(14):e591. PubMed ID: 27045135
[No Abstract] [Full Text] [Related]
6. Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma.
Gagnadoux F; Capron F; Lebeau B
Lung Cancer; 2002 May; 36(2):213-5. PubMed ID: 11955658
[TBL] [Abstract][Full Text] [Related]
7. Favorable response to an endothelin receptor antagonist in mitomycin-induced pulmonary veno-occlusive disease with pulmonary capillary hemangiomatosis.
Koyama M; Yano T; Kikuchi K; Mizuno M; Nagano N; Hashimoto A; Miura T
Int J Cardiol; 2016 Jun; 212():245-7. PubMed ID: 27045880
[No Abstract] [Full Text] [Related]
8. Pharmacovigilance in a rare disease: example of the VIGIAPATH program in pulmonary arterial hypertension.
Chaumais MC; O'Connell C; Savale L; Guignabert C; Perros F; Jaïs X; Sitbon O; Humbert M; Montani D
Int J Clin Pharm; 2018 Aug; 40(4):790-794. PubMed ID: 30101375
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C.
Certain MC; Chaumais MC; Jaïs X; Savale L; Seferian A; Parent F; Georges M; Favrolt N; Bourdin A; Boissin C; Cottin V; Traclet J; Renard S; Noel V; Picard F; Girerd B; Ghigna MR; Perros F; Sitbon O; Bonniaud P; Humbert M; Montani D
Chest; 2021 Mar; 159(3):1197-1207. PubMed ID: 32979348
[TBL] [Abstract][Full Text] [Related]
10. [Familial pulmonary veno-occlusive disease with a composite biallelic heterozygous EIF2AK4 mutation].
Treffel G; Guillaumot A; Gomez E; Eyries M; Petit I; Chabot JF; Chaouat A
Rev Mal Respir; 2020 Dec; 37(10):823-828. PubMed ID: 33071063
[TBL] [Abstract][Full Text] [Related]
11. Recovery from mitomycin-induced pulmonary arterial hypertension.
Botros L; Van Nieuw Amerongen GP; Vonk Noordegraaf A; Bogaard HJ
Ann Am Thorac Soc; 2014 Mar; 11(3):468-70. PubMed ID: 24673706
[No Abstract] [Full Text] [Related]
12. [A not so poorly-defined opacity].
Bravos E; Bayle-Bleuez S; Wahart A; Lachèze R; Forest F; Guichard JB; Bertoletti L
Rev Mal Respir; 2017 Mar; 34(3):249-252. PubMed ID: 27637324
[TBL] [Abstract][Full Text] [Related]
13. No Good Deed Goes Unpunished: Mitomycin-Induced Pulmonary Venoocclusive Disease and Cancer.
De Jesus Perez VA; Zamanian RT
Chest; 2021 Mar; 159(3):910-911. PubMed ID: 33678275
[No Abstract] [Full Text] [Related]
14. Mitomycin C induces pulmonary vascular endothelial-to-mesenchymal transition and pulmonary veno-occlusive disease via Smad3-dependent pathway in rats.
Zhang C; Lu W; Luo X; Liu S; Li Y; Zheng Q; Liu W; Wu X; Chen Y; Jiang Q; Zhang Z; Gu G; Chen J; Chen H; Liao J; Liu C; Hong C; Tang H; Sun D; Yang K; Wang J
Br J Pharmacol; 2021 Jan; 178(1):217-235. PubMed ID: 33140842
[TBL] [Abstract][Full Text] [Related]
15. [Pulmonary veno-occlusive disease developed in a man given long-term treatment with anticancerous agents].
Maemondo M; Ebina A; Saitou K
Nihon Kokyuki Gakkai Zasshi; 1998 Sep; 36(9):823-8. PubMed ID: 9866989
[TBL] [Abstract][Full Text] [Related]
16. Dactinomycin-induced veno-occlusive disease in rats. The hepatoprotective action of amifostine. Evaluation in a light and electron microscope.
Borowska H; Arciszewska E; Czauderna P; Sawicki B
Folia Morphol (Warsz); 2004 Feb; 63(1):91-3. PubMed ID: 15039909
[TBL] [Abstract][Full Text] [Related]
17. Hemolytic uremic syndrome.
Camp-Sorrell D
Oncol Nurs Forum; 2008 Jul; 35(4):593-6. PubMed ID: 18591164
[No Abstract] [Full Text] [Related]
18. Fatal pulmonary venoocclusive disease after use of oral contraceptives.
Townend JN; Roberts DH; Jones EL; Davies MK
Am Heart J; 1992 Dec; 124(6):1643-4. PubMed ID: 1462933
[No Abstract] [Full Text] [Related]
19. Recurrence of pulmonary veno-occlusive disease after heart-lung transplantation.
Izbicki G; Shitrit D; Schechtman I; Bendayan D; Fink G; Sahar G; Saute M; Ben-Gal T; Kramer MR
J Heart Lung Transplant; 2005 May; 24(5):635-7. PubMed ID: 15896767
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary veno-occlusive disease following therapy for malignant neoplasms.
Lombard CM; Churg A; Winokur S
Chest; 1987 Nov; 92(5):871-6. PubMed ID: 3665603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
